CD52 is a molecular target in advanced systemic mastocytosis

  • G. Hoermann, K. Blatt, G. Greiner, E. M. Putz, A. Berger, H. Herrmann, S. Cerny-Reiterer, K. V. Gleixner, C. Walz, K. Hoetzenecker, L. Mullauer, A. Reiter, K. Sotlar, V. Sexl, P. Valent, M. Mayerhofer
  • The FASEB Journal, April 2014, Federation of American Societies For Experimental Biology (FASEB)
  • DOI: 10.1096/fj.14-250894

The authors haven't yet claimed this publication.

Read Publication

http://dx.doi.org/10.1096/fj.14-250894